Skip to main content
Clinical Trials/KCT0008487
KCT0008487
Not Yet Recruiting
N/A

Accuracy evaluation of non-invasive hemodynamic monitor HemoVistaTM (BiLab Co. Ltd. Korea) in the critically ill patients: A prospective observational study

Asan Medical Center0 sites20 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Symptoms, signs and abnormal clinical and laboratory findings, NEC
Sponsor
Asan Medical Center
Enrollment
20
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Adult patients aged 20 or older admitted to the surgical intensive care unit of Asan Medical Center in Seoul, who using arterial catheter cardiac output monitoring device at the time of participation.

Exclusion Criteria

  • Clinically significant arrhythmia (e.g., atrial fibrillation) that may affect the calculation of stroke volume
  • Patients with cardiac pacemakers or defibrillators
  • Patients with mechanical circulation aids, such as an extracorporeal oxygen supply (VA\-ECMO) or an aortic balloon pump (IABP)
  • Patients with trauma or skin lesions in the HemoVistaTM sensor attachment (anterior chest)
  • Any other person deemed inappropriate by researchers

Outcomes

Primary Outcomes

Not specified

Similar Trials